Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,089 JPY | -0.02% | +0.49% | +0.86% |
05:10pm | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
04:07pm | European Medicines Agency Committee Backs Approval of Takeda's Fruquintinib to Treat Colorectal Cancer | MT |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited